Back to Archived Journals » Current Biomarker Findings » Volume 4

Biomarkers in the Ewing sarcoma family of tumors

Authors Machado I, López-Guerrero JA, Llombart-Bosch A

Received 4 March 2014

Accepted for publication 12 April 2014

Published 18 July 2014 Volume 2014:4 Pages 81—92

DOI https://doi.org/10.2147/CBF.S40803

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4


Isidro Machado,1 José Antonio López-Guerrero,2 Antonio Llombart-Bosch3

1Pathology Department, Instituto Valenciano de Oncología, Valencia, Spain; 2Molecular Biology Department, Instituto Valenciano de Oncología, Valencia, Spain; 3Pathology Department, University of Valencia, Valencia, Spain

Abstract: This review provides a concise analysis of the well-characterized phenotypic and biological biomarkers having diagnostic and prognostic significance in the Ewing sarcoma family of tumors. Of particular interest, and potentially high clinical relevance, are studies of cell cycle biomarkers, growth signaling pathway expression, biomarkers related with angiogenesis, epithelial mesenchymal transition, and tumor microenvironment. In addition, we discuss findings of specific interest from recent biomarker studies, including copy number alterations, minimal residual disease and predictive biomarkers, and biological targets such as CD133, insulin-like growth factor 1, and poly(adenosine diphosphate-ribose) polymerase 1. In conclusion, several diagnostic and prognostic biomarkers for the Ewing sarcoma family of tumors have been published in recent years; nevertheless, these all need to be validated in a series of prospective studies. The findings that only a small proportion of patients with relapsed Ewing sarcoma family of tumors respond to targeted therapies serve as an example of the critical need for predictive biomarkers in this disease.

Keywords: Ewing sarcoma, biomarkers, immunohistochemistry, molecular biology


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]